Invizius is a spin-out based on world-class research carried out at the University of Edinburgh, Scotland, developing solutions to improve the treatment and prognosis for dialysis patients.
Despite significant improvements in the quality and efficacy of hemodialysis therapy in recent years, cardiovascular disease (CVD) remains the leading cause of death for dialysis patients. Today, almost half of all dialysis patients die from cardiovascular complications. With its proprietary H-Guard™ technology, Invizius is addressing the side effects of hemodialysis to help patients feel better, and suffer fewer cardiovascular complications.
Despite significant improvements in the quality and efficacy of hemodialysis therapy in recent years, cardiovascular disease (CVD) remains the leading cause of death for dialysis patients. Today, almost half of all dialysis patients die from cardiovascular complications. With its proprietary H-Guard™ technology, Invizius is addressing the side effects of hemodialysis to help patients feel better, and suffer fewer cardiovascular complications.
Location: United Kingdom, Scotland, Motherwell
Employees: 11-50
Total raised: $9.31M
Founded date: 2018
Funding Rounds 3
| Date | Series | Amount | Investors |
| 24.09.2024 | - | $1.27M | - |
| 07.05.2021 | Series A | $7.37M | - |
| 02.05.2018 | - | $678.61K | - |
Mentions in press and media 13
| Date | Title | Description |
| 27.09.2024 | EGYM secures $200M, Mubadala acquires stake in Revolut, and the Hungarian tech surge | This week we tracked more than 90 tech funding deals worth over €1.3 billion, and over 5 exits, M&A transactions, rumours, and related news stories across Europe. In addition to this week's top financials, we've also indexed the most im... |
| 24.09.2024 | Invizius Secures £950K to Revolutionize Dialysis Treatment | In the heart of Edinburgh, a biotech company is on the brink of a breakthrough. Invizius has raised £950,000 in funding, a crucial step toward transforming dialysis treatment. This funding round, led by Mercia Ventures, is a beacon of hope ... |
| 24.09.2024 | Invizius raises £950,000 for dialysis treatment | Invizius, an Edinburgh-based biotech developing breakthrough treatments for patients on dialysis, has raised £950,000 in a funding round led by Mercia Ventures and supported by Calculus Capital, Syensqo, the University of Edinburgh's Old Co... |
| 23.09.2024 | Invizius Raises £950K in Funding | Invizius – Magnus Nicolson Invizius, an Edinburgh, Scotland, UK-based biotech company developing breakthrough treatments for patients on dialysis, raised £950k in funding. The round was led by Mercia Ventures and supported by Calculus Capit... |
| 07.05.2021 | Invizius Closes £5.3M Series A Financing | Invizius Limited, a Motherwell, Scotland, UK-based biotechnology company developing treatments to suppress unwanted innate immune responses, closed Series A financing of £5.3m. The round was led by existing investors Mercia, Downing Venture... |
| 22.10.2019 | Invizius raises £2.75M for its protein coating that hides dialysis machines from the immune system | FierceMedTech Fierce 15 winner Invizius has raised £2.75 million, or about $3.57 million, to help develop its system for mitigating the potential harms and risks of cardiovascular disease linked to dialysis procedures. Sponsored by Agilent ... |
| 22.10.2019 | Invizius raises £2.75M for its protein coating that hides dialysis machines from the immune system | FierceMedTech Fierce 15 winner Invizius has raised £2.75 million, or about $3.57 million, to help develop its system for mitigating the potential harms and risks of cardiovascular disease linked to dialysis procedures. Spun out from the Uni... |
| 09.10.2019 | Mercia helps Edinburgh spin-out raise £2.75m | Invizius, the University of Edinburgh spin-out whose technology could help reduce the high death rates amongst dialysis patients, has raised £2.75m from a consortium of investors. |
| 23.10.2018 | Dialysis pioneer Invizius named ‘Best Innovative MedTech’ | Invizius, a University of Edinburgh spinout whose technology promises to improve the lives of millions of dialysis patients, has been named Best Innovative MedTech company at the prestigious OBN Awards. |
| 02.05.2018 | Invizius Secures £500K in Funding | Invizius, a University of Edinburgh spinout company focused on dialysis technology, secured £500k in funding. Mercia Fund Managers made the investment, which is the first deal since its partnership with the University of Edinburgh was annou... |
Show more